You are here

Eli Lilly

Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?

Motley Fool

Sun, 10/29/23 - 08:44 pm

ulcerative colitis

Crohn's Disease

Lilly’s ulcerative colitis therapy mirikizumab finally snags FDA approval

BioSpace

Fri, 10/27/23 - 11:54 am

ulcerative colitis

Lilly to help BioAge test muscle regeneration therapy in combo with weight loss drug tirzepatide

Fierce Biotech

Thu, 10/26/23 - 10:46 pm

muscle regeneration

Elektrofi and Lilly Enter Multi-Target Research Collaboration and License Agreement

BioSpace

Tue, 10/24/23 - 09:56 am

Eli Lilly sues 11 online pharmacies for allegedly selling unauthorized versions of Mounjaro

Fierce Pharma

Fri, 10/20/23 - 11:35 am

online pharmacies

drug counterfeiting

Eli Lilly plans diabetes drug trial for kids as young as 6 years - Bloomberg

Yahoo/Reuters

Fri, 10/20/23 - 10:02 am

clinical trials

Lilly links up European ADC network, snagging Elahere rival in latest biotech buy

Fierce Biotech

Thu, 10/19/23 - 10:10 am

antibody-drug conjugate

Interest in RNA Editing Accelerates as Therapies Approach the Clinic

BioSpace

Wed, 10/18/23 - 11:37 am

Shape Therapeutics

ProQR Therapeutics

Lilly’s Tirzepatide Shows Strong Weight Loss Efficacy in Phase III Study

BioSpace

Mon, 10/16/23 - 10:17 am

clinical trials

As 'harvest time' arrives for Alzheimer's, neuroscientist reflects on next steps for drug development

Fierce Biotech

Mon, 10/16/23 - 10:12 am

Alzheimer's disease

Lilly’s Mirikizumab Shows Long-Term Remission in Phase III Crohn’s Trial

BioSpace

Thu, 10/12/23 - 05:22 pm

Crohn's Disease

Far More Employers Could Cover Weight Loss Drugs Like Wegovy Next Year—Here’s What That Means For Costs

Forbes

Thu, 10/12/23 - 11:40 am

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

CP Wire/Businesswire

Wed, 10/11/23 - 11:50 pm

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Wed, 10/11/23 - 03:40 pm

Why Eli Lilly Stock Crawled Higher Today

Motley Fool

Mon, 10/9/23 - 11:17 pm

2 Reasons Why Eli Lilly's Mounjaro Might Beat Novo Nordisk's Ozempic, and 2 Reasons Why It Might Not

Motley Fool

Fri, 10/6/23 - 10:08 am

Here's the Best Big Pharma Stock of the Decade so Far (and It's Not Even Close)

Motley Fool

Fri, 10/6/23 - 10:05 am

Lilly names new diabetes and obesity chief as Mounjaro sales take off

BioPharma Dive

Wed, 10/4/23 - 11:23 pm

Lilly Deepens Oncology Pipeline with $1.4B Point Biopharma Purchase

BioSpace

Tue, 10/3/23 - 11:59 am

Point Biopharma

FDA Rejects Lilly’s Eczema Treatment Over Third-Party Manufacturing Issues

BioSpace

Mon, 10/2/23 - 10:36 am

atopic dermatitis

drug manufacturing

Pages